Skip to main content
PMC home page
Gut logoLink to Gut
. 1992 Aug;33(8):1033–1038. doi: 10.1136/gut.33.8.1033

Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus.

J Jankowski 1, G Coghill 1, D Hopwood 1, K G Wormsley 1
PMCID: PMC1379437  PMID: 1398227

Abstract

While the activation of the proto-oncogenes has been implicated in the development and progression of cancer of many tissues, the role of oncogenes in the development of oesophageal adenocarcinoma has not been defined. Fifteen patients who had undergone resection for oesophageal adenocarcinoma and 15 who had undergone oesophagectomy or biopsy for Barrett's oesophagus were studied. The latter patients also had adjacent normal gastric mucosa biopsied for comparison with the metaplastic oesophageal mucosa. The mucosal samples were snap frozen and subsequently stained with monoclonal antibodies to the following oncogene associated proteins; c-erbB2 (neu and CE-1) (external domain), c-erbB2 (NCL-CB11) (internal domain), c-src, c-ras, c-myc, c-fos, c-jun, and the onco-suppressor gene--p53. All tumours were well or moderately differentiated adenocarcinomas arising from the lower third of the oesophagus. Eleven specimens showed strong membraneous staining with both c-erbB2 (neu) and c-erbB2 (CBL-CB11). Seven specimens showed strong nuclear staining with p53 onco-suppressor gene. Three specimens were positive for c-ras and c-src, and two were positive for c-jun. In Barrett's epithelium, nine specimens were positive for c-erbB2 (neu and CB11), three were positive for c-src, two were positive for c-ras and c-jun, and one was positive for c-fos. Two of the gastric mucosal biopsy specimens expressed c-erbB2 weakly but no other oncogenes were found. The frequency of positive staining for c-erbB2 is very high, compared with the expression of these genes in other tumours. It is also concluded that errors in the onco-suppressor gene p53, and especially in the external and internal domains of c-erbB2, which is also often expressed in Barrett's mucosa, may be implicated in the development of adenocarcinoma of the oesophagus.

Full text

PDF
1033

Images in this article

1035Figure 1
on p.1035
1036Figure 2
on p.1036
1036Figure 3
on p.1036
1036Figure 4
on p.1036
1037Figure 5
on p.1037
1037Figure 6
on p.1037

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baserga R. Growth regulation of the PCNA gene. J Cell Sci. 1991 Apr;98(Pt 4):433–436. doi: 10.1242/jcs.98.4.433. [DOI] [PubMed] [Google Scholar]
  2. Benvenisty N. A molecular view of tissue differentiation and development. J R Coll Physicians Lond. 1989 Jul;23(3):156–160. [PMC free article] [PubMed] [Google Scholar]
  3. Corbett I. P., Henry J. A., Angus B., Watchorn C. J., Wilkinson L., Hennessy C., Gullick W. J., Tuzi N. L., May F. E., Westley B. R. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J Pathol. 1990 May;161(1):15–25. doi: 10.1002/path.1711610105. [DOI] [PubMed] [Google Scholar]
  4. Dunn T. L., Seymour G. J., Gardiner R. A., Strutton G. M., Lavin M. F. Immunocytochemical demonstration of p21ras in normal and transitional cell carcinoma urothelium. J Pathol. 1988 Sep;156(1):59–65. doi: 10.1002/path.1711560112. [DOI] [PubMed] [Google Scholar]
  5. Falck V. G., Gullick W. J. c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol. 1989 Oct;159(2):107–111. doi: 10.1002/path.1711590204. [DOI] [PubMed] [Google Scholar]
  6. Going J. J., Williams A. R., Wyllie A. H., Anderson T. J., Piris J. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue. J Pathol. 1988 Jul;155(3):185–190. doi: 10.1002/path.1711550302. [DOI] [PubMed] [Google Scholar]
  7. Gullick W. J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull. 1991 Jan;47(1):87–98. doi: 10.1093/oxfordjournals.bmb.a072464. [DOI] [PubMed] [Google Scholar]
  8. Haldane J. S., Hird V., Hughes C. M., Gullick W. J. c-erbB-2 oncogene expression in ovarian cancer. J Pathol. 1990 Nov;162(3):231–237. doi: 10.1002/path.1711620309. [DOI] [PubMed] [Google Scholar]
  9. Hall P. A., Hughes C. M., Staddon S. L., Richman P. I., Gullick W. J., Lemoine N. R. The c-erb B-2 proto-oncogene in human pancreatic cancer. J Pathol. 1990 Jul;161(3):195–200. doi: 10.1002/path.1711610305. [DOI] [PubMed] [Google Scholar]
  10. Hollstein M. C., Metcalf R. A., Welsh J. A., Montesano R., Harris C. C. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9958–9961. doi: 10.1073/pnas.87.24.9958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hollywood D. Signal transduction. Br Med Bull. 1991 Jan;47(1):99–115. doi: 10.1093/oxfordjournals.bmb.a072465. [DOI] [PubMed] [Google Scholar]
  12. Jankowski J., McMenemin R., Hopwood D., Penston J., Wormsley K. G. Abnormal expression of growth regulatory factors in Barrett's oesophagus. Clin Sci (Lond) 1991 Nov;81(5):663–668. doi: 10.1042/cs0810663. [DOI] [PubMed] [Google Scholar]
  13. Karayiannis M., Yiagnisis M., Papadimitriou K., Spandidos D. A. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa. Anticancer Res. 1989 Nov-Dec;9(6):1505–1510. [PubMed] [Google Scholar]
  14. Maihle N. J., Flickinger T. W., Raines M. A., Sanders M. L., Kung H. J. Native avian c-erbB gene expresses a secreted protein product corresponding to the ligand-binding domain of the receptor. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1825–1829. doi: 10.1073/pnas.88.5.1825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Meltzer S. J., Zhou D., Weinstein W. M. Tissue-specific expression of c-Ha-ras in premalignant gastrointestinal mucosae. Exp Mol Pathol. 1989 Dec;51(3):264–274. doi: 10.1016/0014-4800(89)90024-5. [DOI] [PubMed] [Google Scholar]
  16. Mercer W. E., Shields M. T., Lin D., Appella E., Ullrich S. J. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1958–1962. doi: 10.1073/pnas.88.5.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Novikov L. B., Kalinovskii V. P., Kniazev P. G., Fedorov S. N., Tlevlesov N. Ia. Ekspressiia nekotorykh protoonkogenov v kartsinomakh zheludka cheloveka i v slizistoi obolochke zheludka krys pri gastrokantserogeneze, indutsirovannom N-metil-N'-nitro-N-nitrozoguanidinom. Eksp Onkol. 1989;11(1):18–21. [PubMed] [Google Scholar]
  18. Ravikumar T. S., Wolf B., Cocchiaro C., D'Emilia J., Steele G., Jr Ras gene activation and epidermal growth factor receptor expression in human colon cancer. J Surg Res. 1989 Nov;47(5):418–422. doi: 10.1016/0022-4804(89)90094-2. [DOI] [PubMed] [Google Scholar]
  19. Riddell R. H., Goldman H., Ransohoff D. F., Appelman H. D., Fenoglio C. M., Haggitt R. C., Ahren C., Correa P., Hamilton S. R., Morson B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983 Nov;14(11):931–968. doi: 10.1016/s0046-8177(83)80175-0. [DOI] [PubMed] [Google Scholar]
  20. Rodrigues N. R., Rowan A., Smith M. E., Kerr I. B., Bodmer W. F., Gannon J. V., Lane D. P. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555–7559. doi: 10.1073/pnas.87.19.7555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ryder K., Nathans D. Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8464–8467. doi: 10.1073/pnas.85.22.8464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ryseck R. P., Hirai S. I., Yaniv M., Bravo R. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature. 1988 Aug 11;334(6182):535–537. doi: 10.1038/334535a0. [DOI] [PubMed] [Google Scholar]
  23. Sikora K. Cancer genes in gastrointestinal malignancy. Baillieres Clin Gastroenterol. 1990 Mar;4(1):135–150. doi: 10.1016/0950-3528(90)90043-g. [DOI] [PubMed] [Google Scholar]
  24. Sikora K. The molecules of cancer. The Watson Smith lecture 1990. J R Coll Physicians Lond. 1990 Jul;24(3):196–205. [PMC free article] [PubMed] [Google Scholar]
  25. Soomro S., Shousha S., Taylor P., Shepard H. M., Feldmann M. c-erbB-2 expression in different histological types of invasive breast carcinoma. J Clin Pathol. 1991 Mar;44(3):211–214. doi: 10.1136/jcp.44.3.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Spandidos D. A., Anderson M. L. Oncogenes and onco-suppressor genes: their involvement in cancer. J Pathol. 1989 Jan;157(1):1–10. doi: 10.1002/path.1711570102. [DOI] [PubMed] [Google Scholar]
  27. Takekura N., Yasui W., Yoshida K., Tsujino T., Nakayama H., Kameda T., Yokozaki H., Nishimura Y., Ito H., Tahara E. pp60c-src protein kinase activity in human gastric carcinomas. Int J Cancer. 1990 May 15;45(5):847–851. doi: 10.1002/ijc.2910450510. [DOI] [PubMed] [Google Scholar]
  28. Walker R. A., Senior P. V., Jones J. L., Critchley D. R., Varley J. M. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. J Pathol. 1989 Jun;158(2):97–105. doi: 10.1002/path.1711580204. [DOI] [PubMed] [Google Scholar]
  29. Walker R. A., Wilkinson N. p21 ras protein expression in benign and malignant human breast. J Pathol. 1988 Oct;156(2):147–153. doi: 10.1002/path.1711560209. [DOI] [PubMed] [Google Scholar]
  30. Wasilenko W. J., Nori M., Testerman N., Weber M. J. Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src. Mol Cell Biol. 1990 Mar;10(3):1254–1258. doi: 10.1128/mcb.10.3.1254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yamamoto T., Yasui W., Ochiai A., Ito H., Abe K., Yanaihara N., Tahara E. Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells. Jpn J Cancer Res. 1987 Nov;78(11):1169–1174. [PubMed] [Google Scholar]
  32. Yanagihara K., Seyama T., Tsumuraya M., Kamada N., Yokoro K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res. 1991 Jan 1;51(1):381–386. [PubMed] [Google Scholar]
  33. Yokota J., Yamamoto T., Miyajima N., Toyoshima K., Nomura N., Sakamoto H., Yoshida T., Terada M., Sugimura T. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene. 1988 Mar;2(3):283–287. [PubMed] [Google Scholar]
  34. Yonemura Y., Ninomiya I., Ohoyama S., Kimura H., Yamaguchi A., Fushida S., Kosaka T., Miwa K., Miyazaki I., Endou Y. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer. 1991 Jun 1;67(11):2914–2918. doi: 10.1002/1097-0142(19910601)67:11<2914::aid-cncr2820671134>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  35. Yoshida K., Hamatani K., Koide H., Abe Y., Ikeda H., Tsuchiyama H., Nakayama E., Shiku H. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies. Cancer Detect Prev. 1988;12(1-6):369–376. [PubMed] [Google Scholar]
  36. Yoshida K., Yasui W., Ito H., Tahara E. Growth factors in progression of human esophageal and gastric carcinomas. Exp Pathol. 1990;40(4):291–300. doi: 10.1016/s0232-1513(11)80316-6. [DOI] [PubMed] [Google Scholar]
  37. van den Berg F. M., Tigges A. J., Schipper M. E., den Hartog-Jager F. C., Kroes W. G., Walboomers J. M. Expression of the nuclear oncogene p53 in colon tumours. J Pathol. 1989 Mar;157(3):193–199. doi: 10.1002/path.1711570304. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES